IndustryIntelligence | Medicinal Chemicals & Botanical Products

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

We email documents immediately after purchase. Complete your order by clicking the appropriate Buy button. Please ensure your spam filter will not block TCG's email.

$37	Subscribers Preview	2004	Opinion Letter	Solexa Limited; Manteia SA; James C. Kitch	Lynx; Cooley Godward
$34	Subscribers Preview	2004	Opinion Letter	James C. Kitch; Lynx	Cooley Godward
$30	Subscribers Preview	2004	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$31	Subscribers Preview	2003	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$33	Subscribers Preview	2003	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$38	Subscribers Preview	2002	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$40	Subscribers Preview	2002	Opinion Letter	Friedman, Billings, Ramsey & Co., Inc.; Lynx	Cooley Godward
$36	Subscribers Preview	2001	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$37	Subscribers Preview	2001	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$32	Subscribers Preview	2000	Opinion Letter	Lynx Therapeutics, Inc.	Cooley Godward LLP
$38	Subscribers Preview	2004	Opinion Letter	Mannatech, Inc.	Akin, Gump, Strauss, Hauer & Feld LLP
$32	Subscribers Preview	2000	Opinion Letter	Comdisco Holding; Maxim Pharma	Cooley Godward
$32	Subscribers Preview	2003	Opinion Letter	Neose Technologies, Inc.	Pepper Hamilton LLP
$31	Subscribers Preview	2000	Opinion Letter	Tapestry Pharmaceuticals, Inc.	Holme Roberts & Owen
$35	Subscribers Preview	2001	Opinion Letter Re: Bio-Technology General Corp. Registration Statement on Form S-3	Savient Pharma; TCG	Fulbright
$32	Subscribers Preview	2000	Opinion Letter Re: Cyanotech Corporation Registration Statement Form S-8	Cyanotech Corp.